Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Director/PDMR Shareholding

16 Dec 2019 07:00

RNS Number : 8847W
Velocys PLC
16 December 2019
 

News release

Velocys plc

("Velocys" or "the Company")

16 December 2019

 

Grant of Share Options to Directors

Velocys plc (VLS.L), the sustainable fuels technology company announces that it has been notified on 13 December 2019 by Henrik Wareborn, Chief Executive Officer and a director of the Company, and Andrew Morris, Chief Financial Officer and a director of the Company, that they were granted options ("Option Grants") on 13 December 2019 under the Velocys 2012 Share Option Scheme (as amended) over the Company's Ordinary shares of £0.01 each ("Ordinary Shares"). The Option Grants, which have been made under the Rules of the Velocys 2012 Share Option Scheme and follow discussions with major shareholders, were as follows:

 

 

Name of Director

Type of share option

Number of share options granted

 

Exercise price

Vesting/

Exercise

(See notes below)

Total number of share options as % of present issued share capital

 Henrik Wareborn

Commencement Award

Performance Award

Annual Award 2019

2,000,000

2,000,000

6,250,000

£0.10

£0.15

£0.03

 

Note 1

Note 2

Note 3

0.31%

0.31%

0.97%

Andrew Morris

Commencement Award

Performance Award

Annual Award 2019

2,000,000

2,000,000

5,625,000

£0.10

£0.15

£0.03

 

Note 1

Note 2

Note 3

0.31%

0.31%

0.87%

 

Following these notifications:

 

(i) Henrik Wareborn is interested in 1,666,666 Ordinary Shares and Options over 10,250,000 Ordinary Shares of the Company, together representing 1.85% of the present issued share capital of the Company.

 

(ii) Andrew Morris is interested in 433,333 Ordinary Shares and Options over 9,625,000 Ordinary Shares of the Company, together representing 1.56% of the present issued share capital of the Company.

 

The Option Grants are in addition to one-off Special Awards of share options over 16,700,000 Ordinary Shares (representing 2.59% of the present issued share capital) to Velocys' other key staff to compensate for an absence of share awards in recent years, and of share options over 15,250,146 Ordinary Shares (representing 2.37% of the present issued share capital) to Velocys' other key staff in respect of share awards for the 2019 financial year.

 

The above options are subject to terms for Malus and Clawback and may not in any event be exercised later than the day immediately preceding the tenth anniversary of the date of grant.

 

Note 1: Commencement awards vest as to two-thirds on the date of grant and as to the balance on 4 December 2020.

 

Note 2: Performance Awards are only exercisable subject to the weighted average share price of an Ordinary Share being equal to or more than £0.15 measured during specified periods within the performance period which expires on 31 December 2022.

 

Note 3: Annual awards vest as to:

 

(i) 50% on the third anniversary of the date of grant and

(ii) 50% on the third anniversary of the date of grant subject to the weighted average share price of an Ordinary Share being equal to or more than £0.045 during the month preceding the third anniversary of the date of grant.

 

 

- Ends -

 

For further information, please contact:

Velocys

Henrik Wareborn, CEO

Andrew Morris, CFO

 

+44 1865 800821

Numis Securities (Nomad and joint broker)

Stuart Skinner

Tom Ballard

 

+44 20 7260 1000

Canaccord Genuity (Joint broker)

Henry Fitzgerald-O'Connor

James Asensio

+44 20 7523 8000  

Radnor Capital (Investor relations)

Joshua Cryer

Iain Daly

 

+44 20 3897 1830

 

Field Consulting (PR)

Robert Jeffery

 +44 20 7096 7730

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMMMZKFZGLZM
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.